Article Details
Retrieved on: 2018-04-08 20:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Constellation Pharmaceuticals, a company focused on developing small molecule therapies for difficult-to-treat cancers has raised $100 million from a group of old and new investors. The Cambridge, Mass-based company has been around since 2008, but is now gaining momentum with its lead ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here